ストックスクリーナーアプリを入手
17.02
3.08%
-0.54
アフターアワーズ：
17.02
前日終値:
$17.56
開ける：
$17.56
24時間の取引高:
212.96K
Relative Volume:
0.61
時価総額：
$333.50M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+2.04%
1か月 パフォーマンス:
-28.96%
6か月 パフォーマンス:
-52.63%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$16.83
$17.84
1週間の範囲:
$15.96
$18.49
52週間の値動き範囲:
$13.70
$61.07
Tectonic Therapeutic Inc Stock (TECX) Company Profile
TECX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
17.02 | 333.50M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-20 | 開始されました | Raymond James | Outperform |
| 2024-08-22 | 開始されました | Wells Fargo | Overweight |
| 2024-06-26 | 開始されました | Piper Sandler | Overweight |
| 2024-06-24 | 開始されました | TD Cowen | Buy |
| 2023-12-18 | ダウングレード | Mizuho | Buy → Neutral |
| 2022-01-05 | ダウングレード | BTIG Research | Buy → Neutral |
| 2021-11-19 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-15 | 開始されました | BTIG Research | Buy |
| 2021-05-27 | 開始されました | Needham | Buy |
| 2021-03-09 | 開始されました | Barclays | Overweight |
| 2021-03-02 | 開始されました | Stifel | Hold |
| 2020-11-11 | 開始されました | Berenberg | Buy |
| 2020-03-31 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2019-06-27 | 開始されました | Mizuho | Buy |
| 2019-04-05 | 開始されました | Janney | Buy |
| 2018-10-10 | 開始されました | Guggenheim | Buy |
| 2018-10-02 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-09-17 | 開始されました | H.C. Wainwright | Buy |
| 2018-07-16 | 開始されました | Wedbush | Outperform |
| 2018-07-16 | 開始されました | Wells Fargo | Outperform |
すべてを表示
Tectonic Therapeutic Inc (TECX) 最新ニュース
Tectonic Therapeutic Inc (NASDAQ: TECX): Blank Check For Growth? - stocksregister.com
Vanguard Group Inc. Has $16.67 Million Position in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic To Present Phase 1B Data For Tx45 At European Society Of Cardiology Heart Failure 2025 - marketscreener.com
Tectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025 - GlobeNewswire
Major Breakthrough: New Phase 1b Heart Failure Drug Data Promises Key Insights at ESC 2025 - Stock Titan
Tectonic Therapeutic Insider Bought Shares Worth $2,299,015, According to a Recent SEC Filing - MarketScreener
Raymond James Financial Inc. Takes Position in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Major Investment Alert: Insider Buys Big in Tectonic Therapeutic! - TipRanks
Tectonic Therapeutic director Timothy Springer acquires $2.3 million in shares - Investing.com
Commonwealth Equity Services LLC Takes $231,000 Position in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Hedge Fund and Insider Trading News: Ray Dalio, Bill Ackman, John Hempton, Ken Griffin, George Soros, Eisler Capital, Tectonic Therapeutic Inc (TECX), BigBear.ai Holdings Inc (BBAI), and More - Insider Monkey
Tectonic therapeutic director Timothy Springer acquires $8.55 million in shares By Investing.com - Investing.com South Africa
Tectonic therapeutic director Timothy Springer acquires $8.55 million in shares - Investing.com Canada
Director’s Bold Move: Massive Stock Sale Shakes Tectonic Therapeutic! - TipRanks
Tectonic therapeutic director Terrance McGuire sells $8.55m in stock By Investing.com - Investing.com South Africa
Tectonic therapeutic director Terrance McGuire sells $8.55m in stock - Investing.com
Tectonic Therapeutic Reports Strong 2024 Financial Results - TipRanks
Charles Schwab Investment Management Inc. Invests $218,000 in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Receives $77.75 Average Price Target from Brokerages - Defense World
Tectonic Therapeutic: Buy Rating Affirmed on Strong Financials and Promising Pipeline - TipRanks
Wells Fargo & Company Lowers Tectonic Therapeutic (NASDAQ:TECX) Price Target to $101.00 - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Given New $101.00 Price Target at Wells Fargo & Company - Armenian Reporter
Tectonic Therapeutic Inc. (TECX) reports earnings - Quartz
Tectonic Therapeutic Announces Fourth Quarter And Full Year 2024 Financial Results And Recent Business Highlights - Marketscreener.com
Tectonic Therapeutic Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Tectonic Therapeutic, Inc. SEC 10-K Report - TradingView
Tectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - GlobeNewswire
Tectonic's TX45 Trial Achieves 30% Disease Reduction, Extends Runway to 2028 - StockTitan
Tectonic Therapeutic Inc expected to post a loss of $1.39 a shareEarnings Preview - TradingView
Tectonic Therapeutic director Timothy Springer buys $39.9 million in stock - MSN
Tectonic Therapeutic (TECX) Expected to Announce Quarterly Earnings on Thursday - Defense World
Is Tectonic Therapeutic, Inc. (TECX) Among Stocks With At Least $20 Million In Insider Spending Recently? - Insider Monkey
10 Stocks With At Least $20 Million In Insider Spending Recently - Insider Monkey
Brokerages Set Tectonic Therapeutic (NASDAQ:TECX) Price Target at $80.50 - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Given Average Rating of "Buy" by Brokerages - MarketBeat
Tectonic Therapeutic, Inc. (TECX): Among the Most Expensive Stocks Insiders Are Buying Recently - Insider Monkey
11 Most Expensive Stocks Insiders Are Buying Recently - Insider Monkey
Tectonic Therapeutic to Participate in March Investor Conferences - The Manila Times
Exclusive Access: Tectonic's Management Team Opens Door to Investors at Major March Conferences - StockTitan
Tectonic Therapeutic (NASDAQ:TECX) Sees Significant Growth in Short Interest - MarketBeat
Fresh Tracks Therapeutics (NASDAQ:FRTX) vs. Tectonic Therapeutic (NASDAQ:TECX) Head to Head Comparison - Armenian Reporter
Analyzing Fresh Tracks Therapeutics (NASDAQ:FRTX) and Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic jumps on positive data from early-stage trial for lead asset - MSN
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Up Following Insider Buying Activity - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Director Timothy A. Springer Buys 129,294 Shares - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Trading Down 3.2%Should You Sell? - MarketBeat
Daniel Lochner Acquires 4,617 Shares of Tectonic Therapeutic (NASDAQ:TECX) Stock - MarketBeat
Tectonic Therapeutic Inc (TECX) 財務データ
Tectonic Therapeutic Inc (TECX) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
2.51%
大文字化:
|
ボリューム (24 時間):